Cargando…

Sentinel lymph node identification by blue dye in patients with breast carcinoma

OBJECTIVE: To determine the diagnostic accuracy of methylene blue dye to detect axillary lymph node metastases in patients with breast carcinoma by taking histopathology as gold standard. METHODS: This quasi experimental study was done at Department of Surgery of Dow University Hospital Karachi duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakhtiar, Nighat, Jaleel, Farhat, Moosa, Foad Ali, Qureshi, Naeem Akhtar, Jawaid, Masood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859042/
https://www.ncbi.nlm.nih.gov/pubmed/27182259
http://dx.doi.org/10.12669/pjms.322.9563
_version_ 1782430898007834624
author Bakhtiar, Nighat
Jaleel, Farhat
Moosa, Foad Ali
Qureshi, Naeem Akhtar
Jawaid, Masood
author_facet Bakhtiar, Nighat
Jaleel, Farhat
Moosa, Foad Ali
Qureshi, Naeem Akhtar
Jawaid, Masood
author_sort Bakhtiar, Nighat
collection PubMed
description OBJECTIVE: To determine the diagnostic accuracy of methylene blue dye to detect axillary lymph node metastases in patients with breast carcinoma by taking histopathology as gold standard. METHODS: This quasi experimental study was done at Department of Surgery of Dow University Hospital Karachi during January 2013 to September 2015 after the approval of Hospital Ethical Committee. A total number of 85 patients with biopsy proven carcinoma were included in the study.1% methylene blue dye was infiltrated in the peri tumoural area of the diseased breast. The blue stained node called sentinel lymph node (SLN) was recognized and carefully dissected out. SLN and mastectomy with axillary clearance specimen was sent for histopathology in two separate bottles and the report of the histopathology was compared. RESULTS: The axillary lymph nodes were positive for carcinoma in 61 cases out of 85(71.7%). Two of the patients had negative sentinel lymph node but positive non sentinel lymph node (false negative), and in three cases sentinel lymph node were involved only but not the rest of the axilla (False positive). The sensitivity, specificity and accuracy were 96.8%,86.36% and 94.1% respectively. CONCLUSION: Methylene blue dye technique is a reliable and safe diagnostic modality for detection of Sentinel lymph node in breast cancer patient because of its high accuracy.
format Online
Article
Text
id pubmed-4859042
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-48590422016-05-13 Sentinel lymph node identification by blue dye in patients with breast carcinoma Bakhtiar, Nighat Jaleel, Farhat Moosa, Foad Ali Qureshi, Naeem Akhtar Jawaid, Masood Pak J Med Sci Original Article OBJECTIVE: To determine the diagnostic accuracy of methylene blue dye to detect axillary lymph node metastases in patients with breast carcinoma by taking histopathology as gold standard. METHODS: This quasi experimental study was done at Department of Surgery of Dow University Hospital Karachi during January 2013 to September 2015 after the approval of Hospital Ethical Committee. A total number of 85 patients with biopsy proven carcinoma were included in the study.1% methylene blue dye was infiltrated in the peri tumoural area of the diseased breast. The blue stained node called sentinel lymph node (SLN) was recognized and carefully dissected out. SLN and mastectomy with axillary clearance specimen was sent for histopathology in two separate bottles and the report of the histopathology was compared. RESULTS: The axillary lymph nodes were positive for carcinoma in 61 cases out of 85(71.7%). Two of the patients had negative sentinel lymph node but positive non sentinel lymph node (false negative), and in three cases sentinel lymph node were involved only but not the rest of the axilla (False positive). The sensitivity, specificity and accuracy were 96.8%,86.36% and 94.1% respectively. CONCLUSION: Methylene blue dye technique is a reliable and safe diagnostic modality for detection of Sentinel lymph node in breast cancer patient because of its high accuracy. Professional Medical Publications 2016 /pmc/articles/PMC4859042/ /pubmed/27182259 http://dx.doi.org/10.12669/pjms.322.9563 Text en Copyright: © Pakistan Journal of Medical Sciences http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Bakhtiar, Nighat
Jaleel, Farhat
Moosa, Foad Ali
Qureshi, Naeem Akhtar
Jawaid, Masood
Sentinel lymph node identification by blue dye in patients with breast carcinoma
title Sentinel lymph node identification by blue dye in patients with breast carcinoma
title_full Sentinel lymph node identification by blue dye in patients with breast carcinoma
title_fullStr Sentinel lymph node identification by blue dye in patients with breast carcinoma
title_full_unstemmed Sentinel lymph node identification by blue dye in patients with breast carcinoma
title_short Sentinel lymph node identification by blue dye in patients with breast carcinoma
title_sort sentinel lymph node identification by blue dye in patients with breast carcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859042/
https://www.ncbi.nlm.nih.gov/pubmed/27182259
http://dx.doi.org/10.12669/pjms.322.9563
work_keys_str_mv AT bakhtiarnighat sentinellymphnodeidentificationbybluedyeinpatientswithbreastcarcinoma
AT jaleelfarhat sentinellymphnodeidentificationbybluedyeinpatientswithbreastcarcinoma
AT moosafoadali sentinellymphnodeidentificationbybluedyeinpatientswithbreastcarcinoma
AT qureshinaeemakhtar sentinellymphnodeidentificationbybluedyeinpatientswithbreastcarcinoma
AT jawaidmasood sentinellymphnodeidentificationbybluedyeinpatientswithbreastcarcinoma